RET and cancer: In the absence of a ligand, the RET protein is a single unphosphorylated tyrosine kinase receptor, but in cancer cells, single point mutations in the RET proto-oncogene lead to the autophosphorylation of tyrosine residues, which consequently induces the constitutive activation of the RET receptor and a permanent gain-of-function12, 13.